Annis Gardner Whiting Capital Advisors’s ResMed RMD Stock Holding History

Annis Gardner Whiting Capital Advisors’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-102	Closed	-$22.9K	–	1052
2026 Q1	$22.9K	Sell	102 -19	-16%	-$4.74K	﹤0.01%	702
2025 Q4	$29.1K	Buy	121 +2	+2%	+$511	0.01%	597
2025 Q3	$32.6K	Buy	119 +2	+2%	+$546	0.01%	548
2025 Q2	$30.2K	Buy	117 +34	+41%	+$8.11K	0.01%	491
2025 Q1	$18.6K	Buy	83 +7	+9%	+$1.63K	0.01%	471
2024 Q4	$17.4K	Hold	76	–	–	﹤0.01%	461
2024 Q3	$18.6K	Sell	76 -3	-4%	-$670	0.01%	468
2024 Q2	$15.1K	Buy	79 +3	+4%	+$609	﹤0.01%	621
2024 Q1	$15.1K	Buy	76 +3	+4%	+$550	0.01%	612
2023 Q4	$12.6K	Hold	73	–	–	0.01%	455
2023 Q3	$10.8K	Buy	+73	New	+$13.2K	0.01%	454

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Annis Gardner Whiting Capital Advisors's RMD Position: Q2 2026 in Review

Annis Gardner Whiting Capital Advisors sold out of ResMed (RMD) in Q2 2026, closing a stake of 102 shares — an estimated $22.9K sold.

Annis Gardner Whiting Capital Advisors first reported a position in RMD in Q3 2023 and held it in 11 quarters. The position peaked at $32.6K in Q3 2025. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Annis Gardner Whiting Capital Advisors reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
Annis Gardner Whiting Capital Advisors sold 102 ResMed shares in Q2 2026, an estimated $22.9K.
Annis Gardner Whiting Capital Advisors first reported a position in ResMed in Q3 2023 and held it in 11 quarters.
Annis Gardner Whiting Capital Advisors's ResMed position peaked at $32.6K in Q3 2025.
891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Annis Gardner Whiting Capital Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.